|
Market Closed -
Boerse Muenchen
04:44:31 29/08/2026 HKT
|
5-day change | 1st Jan Change | ||
| 172.00 EUR | -2.80% |
|
-3.40% | +33.70% |
| 08-12 | UBS Adjusts Price Target on Axsome Therapeutics to $280 From $259, Keeps Buy Rating | MT |
| 08-12 | Mizuho Adjusts PT on Axsome Therapeutics to $316 From $306, Keeps Outperform Rating | MT |
| Market Cap | 10.42B 8.98B 8.42B 7.69B 14.48B 996B 14.53B 99.93B 38.99B 503B 39.14B 38.29B 1,668B | P/E 2026 * |
-74.4x | P/E 2027 * | 43.2x |
|---|---|---|---|---|---|
| Enterprise Value | 10.27B 8.85B 8.3B 7.57B 14.27B 981B 14.31B 98.43B 38.4B 495B 38.55B 37.71B 1,643B | EV / Sales 2026 * |
10.6x | EV / Sales 2027 * | 6.39x |
| Free-Float |
84.69% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Axsome Therapeutics, Inc.
| 1 week | -3.40% | ||
| Current month | -9.11% | ||
| 1 month | -16.46% | ||
| 3 months | -14.00% | ||
| 6 months | +24.14% | ||
| Current year | +33.70% |
| 1 week | 171.35 |  | 180.3 |
| 1 month | 171.35 | | 209.2 |
| 3 years | 52.74 | | 225.3 |
| 5 years | 19.48 | | 225.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 12/01/2012 | |
Nick Pizzie
DFI | Director of Finance/CFO | 51 | 16/05/2018 |
Mark Jacobson
COO | Chief Operating Officer | 42 | 01/04/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 57 | 12/01/2012 | |
Roger Jeffs
BRD | Director/Board Member | 64 | 01/12/2014 |
Mark Coleman
BRD | Director/Board Member | 58 | 01/12/2014 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.80% | -3.40% | +64.51% | +134.84% | 10.42B | |
| -1.67% | -4.78% | +36.76% | -4.34% | 79.3B | |
| -0.90% | +2.39% | -19.06% | -35.50% | 59.21B | |
| -3.35% | -4.92% | +472.81% | +18.97% | 55.09B | |
| -6.78% | -4.19% | -3.45% | +28.35% | 49.86B | |
| -2.43% | -2.35% | +8.33% | +160.40% | 47.9B | |
| -1.35% | +0.79% | +65.25% | -18.47% | 32.28B | |
| -2.64% | -2.69% | +46.99% | +92.55% | 25.21B | |
| -0.09% | +4.98% | +11.00% | +199.86% | 23.87B | |
| -0.34% | +1.35% | +62.33% | +122.21% | 16.89B | |
| Average | -2.17% | -1.20% | +74.55% | +69.89% | 43.29B | |
| Weighted average by Cap. | -2.42% | -2.05% | +83.34% | +44.18% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 966M 833M 781M 713M 1.34B 92.35B 1.35B 9.26B 3.61B 46.62B 3.63B 3.55B 155B | 1.56B 1.35B 1.26B 1.15B 2.17B 149B 2.18B 14.97B 5.84B 75.36B 5.86B 5.74B 250B |
| Net income | -140M -121M -113M -103M -195M -13.41B -196M -1.35B -525M -6.77B -527M -515M -22.45B | 255M 220M 206M 188M 355M 24.4B 356M 2.45B 955M 12.32B 959M 938M 40.85B |
| Net Debt | -156M -135M -126M -115M -217M -14.95B -218M -1.5B -585M -7.55B -587M -575M -25.03B | -435M -375M -352M -321M -605M -41.61B -607M -4.17B -1.63B -21B -1.63B -1.6B -69.64B |
| Date | Price | Change |
|---|---|---|
| 28/08/26 | €172.00 | -2.80% |
| 27/08/26 | €176.95 | -0.59% |
| 26/08/26 | €178.00 | +1.48% |
| 25/08/26 | €175.40 | -0.57% |
| 24/08/26 | €176.40 | -0.93% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AXSM Stock
- 19X Stock
Select your edition
All financial news and data tailored to specific country editions
